1-13 of 13
Giancarlo Viberti
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Vascular Progenitor Cells in Patients With Type 1 Diabetes and Microalbuminuria

Open Access
Cecile Dessapt, PHD, Janaka Karalliedde, MRCP, Maria Hernandez-Fuentes, PHD, Paz Prieto Martin, MS, Giuseppe Maltese, MD, Nikesh Dattani, MBBS, Ravinder Atkar, MBBS, GianCarlo Viberti, FRCP, Luigi Gnudi, MD
Journal: Diabetes Care
Diabetes Care 2010;33(4):875–877
https://doi.org/10.2337/dc09-1468
Published: 12 January 2010
View article titled, Circulating Vascular Progenitor Cells in Patients With Type 1 Diabetes and Microalbuminuria
Open the PDF for Circulating Vascular Progenitor Cells in Patients With Type 1 Diabetes and Microalbuminuria in another window
Includes: Supplementary data
Journal Articles

Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)

Open Access
Steven E. Kahn, MB, CHB, Steven M. Haffner, MD, Giancarlo Viberti, MD, William H. Herman, MD, John M. Lachin, SCD, Barbara G. Kravitz, MS, Dahong Yu, PHD, Gitanjali Paul, PHD, Rury R. Holman, MD, Bernard Zinman, MD, for A Diabetes Outcome Progression Trial (ADOPT) Study Group
Journal: Diabetes Care
Diabetes Care 2010;33(1):177–183
https://doi.org/10.2337/dc09-1661
Published: 06 October 2009
View article titled, Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)
Open the PDF for Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT) in another window
Journal Articles

Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)

Free
Steven E. Kahn, MB, CHB, Bernard Zinman, MD, John M. Lachin, SCD, Steven M. Haffner, MD, William H. Herman, MD, Rury R. Holman, MD, Barbara G. Kravitz, MS, Dahong Yu, PHD, Mark A. Heise, PHD, R. Paul Aftring, MD, PHD, Giancarlo Viberti, MD, for the A Diabetes Outcome Progression Trial (ADOPT) Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(5):845–851
https://doi.org/10.2337/dc07-2270
Published: 01 May 2008
View article titled, Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
Open the PDF for Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT) in another window
Includes: Supplementary data
Journal Articles

HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes

Free
Per-Henrik Groop, MD, DMSC, Merlin C. Thomas, MBCHB, PHD, Milla Rosengård-Bärlund, MD, Vashti Mills, BSC, Mats Rönnback, MD, Stephen Thomas, PHD, MRCP, Carol Forsblom, MD, DMSC, Maria-Rita Taskinen, MD, DMSC, Giancarlo Viberti, FRCP
Journal: Diabetes Care
Diabetes Care 2007;30(10):2706–2707
https://doi.org/10.2337/dc07-0030
Published: 01 October 2007
View article titled, HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes
Open the PDF for HDL Composition Predicts New-Onset Cardiovascular Disease in Patients With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes

Free
Merlin C. Thomas, MBCHB, PHD, FRACP, Milla Rosengård-Bärlund, MD, Vashti Mills, BSC, Mats Rönnback, MD, Stephen Thomas, PHD, MRCP, Carol Forsblom, MD, DMSC, Mark E. Cooper, MBBS, PHD, Marja-Riitta Taskinen, MD, DMSC, Giancarlo Viberti, MD, FRCP, Per-Henrik Groop, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(2):317–322
https://doi.org/10.2337/diacare.29.02.06.dc05-0809
Published: 01 February 2006
View article titled, Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes
Open the PDF for Serum Lipids and the Progression of Nephropathy in Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Determinants of Response to Insulin Therapy Following Failure of Oral Agents in Type 2 Diabetes

Free
Janaka Karalliedde, MRCP, Andy Smith, MRCP, Giancarlo Viberti, MD, FRCP
Journal: Diabetes Care
Diabetes Care 2005;28(10):2589–2590
https://doi.org/10.2337/diacare.28.10.2589
Published: 01 October 2005
View article titled, Determinants of Response to Insulin Therapy Following Failure of Oral Agents in Type 2 Diabetes
Open the PDF for Determinants of Response to Insulin Therapy Following Failure of Oral Agents in Type 2 Diabetes in another window
Journal Articles

Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents

Free
Cecilia Invitti, MD, Gabriele Guzzaloni, MD, Luisa Gilardini, MD, Francesco Morabito, MD, Giancarlo Viberti, MD, FRCP
Journal: Diabetes Care
Diabetes Care 2003;26(1):118–124
https://doi.org/10.2337/diacare.26.1.118
Published: 01 January 2003
View article titled, Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents
Open the PDF for Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents in another window
Journal Articles

A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes

Free
Giancarlo Viberti, MD, Steven E. Kahn, MB, CHB, Douglas A. Greene, MD, William H. Herman, MD, Bernard Zinman, MD, Rury R. Holman, MD, Steven M. Haffner, MD, Daniel Levy, MD, John M. Lachin, SCD, Rhona A. Berry, BSC, Mark A. Heise, PHD, Nigel P. Jones, MA, Martin I. Freed, MD
Journal: Diabetes Care
Diabetes Care 2002;25(10):1737–1743
https://doi.org/10.2337/diacare.25.10.1737
Published: 01 October 2002
View article titled, A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes
Open the PDF for A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes in another window
Journal Articles

Does Microalbuminuria Predict Diabetic Nephropathy?

Free
Han-Henrik Parving, Nish Chaturvedi, MD, GianCarlo Viberti, MD, FRCP, Carl Erik Mogensen, MD
Journal: Diabetes Care
Diabetes Care 2002;25(2):406–407
https://doi.org/10.2337/diacare.25.2.406
Published: 01 February 2002
View article titled, Does Microalbuminuria Predict Diabetic Nephropathy?
Open the PDF for Does Microalbuminuria Predict Diabetic Nephropathy? in another window
Journal Articles

Plasma Cholesteryl Ester Transfer Protein and Its Relationship to Plasma Lipoproteins and Apolipoprotein A-I-Containing Lipoproteins in IDDM Patients With Microalbuminuria and Clinical Nephropathy

Free
Juhani Kahri, MD, Per-Henrik Groop, MD, Tom Elliott, MD, Giancarlo Viberti, MD, Marja-Riitta Taskinen, MD
Journal: Diabetes Care
Diabetes Care 1994;17(5):412–419
https://doi.org/10.2337/diacare.17.5.412
Published: 01 May 1994
View article titled, Plasma Cholesteryl Ester Transfer Protein and Its Relationship to Plasma Lipoproteins and Apolipoprotein A-I-Containing Lipoproteins in IDDM Patients With Microalbuminuria and Clinical Nephropathy
Open the PDF for Plasma Cholesteryl Ester Transfer Protein and Its Relationship to Plasma Lipoproteins and Apolipoprotein A-I-Containing Lipoproteins in IDDM Patients With Microalbuminuria and Clinical Nephropathy in another window
Journal Articles

Serum Sialic Acid, a Risk Factor for Cardiovascular Disease, Is Increased in IDDM Patients With Microalbuminuria and Clinical Proteinuria

Free
Martin A Crook, MB, PHD, Kenneth Earle, MRCP, Anna Morocutti, MD, Jeannie Yip, MRCP, Giancarlo Viberti, MD, John C Pickup, BM, DPHIL
Journal: Diabetes Care
Diabetes Care 1994;17(4):305–310
https://doi.org/10.2337/diacare.17.4.305
Published: 01 April 1994
View article titled, Serum Sialic Acid, a Risk Factor for Cardiovascular Disease, Is Increased in IDDM Patients With Microalbuminuria and Clinical Proteinuria
Open the PDF for Serum Sialic Acid, a Risk Factor for Cardiovascular Disease, Is Increased in IDDM Patients With Microalbuminuria and Clinical Proteinuria in another window
Journal Articles

Diabetic Nephropathy: Future avenue

Free
GianCarlo Viberti, MD, Jeannie Yip-Messent, MB, Anna Morocutti, MD
Journal: Diabetes Care
Diabetes Care 1992;15(9):1216–1225
https://doi.org/10.2337/diacare.15.9.1216
Published: 01 September 1992
View article titled, Diabetic Nephropathy: Future avenue
Open the PDF for Diabetic Nephropathy: Future avenue in another window
Journal Articles

Etiology and Prognostic Significance of Albuminuria in Diabetes

Free
Giancarlo Viberti, MD, MRCP
Journal: Diabetes Care
Diabetes Care 1988;11(10):840–845
https://doi.org/10.2337/diacare.11.10.840
Published: 01 November 1988
View article titled, Etiology and Prognostic Significance of Albuminuria in Diabetes
Open the PDF for Etiology and Prognostic Significance of Albuminuria in Diabetes in another window